Tuesday, May 22, 2018

ICU-ROX - results of the pilot phase

Intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX): results of the pilot phase.

Young PJ, Mackle DM, et al.; The ICU-ROX pilot investigators; The Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2017 Dec;19(4):344-354.



The objective of the intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX) pilot phase, which included the first 100 patients of an overall sample of 1000, was to examine feasibility.


Investigator-initiated, prospective, parallel-group, pilot randomised controlled trial.


Six medical-surgical intensive care units (ICUs) in Australia and New Zealand, with participants recruited from September 2015 through June 2016.


100 patients ≥ 18 years of age who required invasive mechanical ventilation in the ICU and were expected to be receiving it beyond the next calendar day at the time of randomisation.


Conservative oxygen therapy or standard care.


Eligibility, recruitment rate, and separation in oxygen exposure (fraction of inspired oxygen [FiO2] and oxygen saturation measured by pulse oximetry [SpO2Z]).


94 of 99 participants (94.9%) were confirmed by study monitors to fulfil the study eligibility criteria. 3.6 patients per site per month were enrolled (95% confidence interval [CI], 2.5-4.7). Patients allocated to conservative oxygen therapy spent significantly more time on an FiO2 of 0.21 in the ICU; median, 31.5 hours (interquartile range [IQR], 7-63.5) for conservative oxygen therapy patients v 0 hours for standard oxygen therapy patients (IQR, 0-10; midpoint difference, 21.5 hours; 95% CI, 9-34; P < 0.0001). Patients allocated to conservative oxygen therapy spent less time in the ICU with an SpO2Z of ≥ 97% than patients allocated to standard oxygen therapy; median, 18.5 hours (IQR, 5-46) for conservative oxygen therapy patients v 32 hours for standard oxygen therapy (IQR, 17-80; midpoint difference, 13.5 hours; 95% CI, 2-25; P = 0.02).


Our findings confirm the feasibility of completing the ICU-ROX trial without the need for substantive changes to the study protocol for the remaining 900 trial participants.
To find the article - Click here

No comments:

Post a Comment


Information provided here is for medical education only. It is not intended as and does not substitute for medical advice. If you are a patient, please see your doctor for evaluation of your individual case. The web site should not be used as a substitute for competent medical advice from a licensed physician. By accessing the web site, the visitors acknowledge that there is no physician-patient relationship between them and the author. Under no circumstances will the author be liable to you for any direct or indirect damages arising in connection with use of this website.

The appearance of external hyperlinks to other websites does not constitute endorsement. The author does not verify, endorse, or take responsibility for the accuracy, currency, completeness or quality of the content contained in these sites.

All information provided here is from textbooks/journals. I have provided references and given credit where applicable. I would be glad to take off any images/posts that you think violates your copyright policy. Please shoot an email to fnbcriticare@gmail.com